Ajanta Pharma Sees 17% Upside Potential

Ajanta Pharma is a company that makes medicines.

A group called Motilal Oswal thinks the company's stock could go up by 17%.

They believe this because Ajanta is doing well in India and is trying to sell its products in new places like Africa and the Middle East.

They are also adding new medicines to their collection, especially ones that help with long-term health problems.

The company is working with another company, Biocon, to sell a medicine called semaglutide, which helps with weight loss.

Even though the company's earnings might grow slowly at first, the group thinks things will get better in the next few years.

They also think that even if the price of semaglutide goes down, the company will still do well because there is a lot of demand for their products.